Ian Stewart, Author at Cannabis Business Executive - Cannabis and Marijuana industry news

Cannabis Home Delivery Tech Platform Accused of Conspiring with California Retailers to Commit Credit Card Laundering and Fraud

On June 4, 2019, Eaze Technologies Inc. (Eaze) was sued in San Francisco County Superior Court by its competitor Herban Industries CA LLC (Herban), alleging a conspiracy between Eaze and numerous California cannabis dispensaries to commit payment and credit card…

USDA Issues Legal Opinion Supporting Current Legality of Hemp in Interstate Commerce

On May 28, 2019, the U.S. Department of Agriculture Office of General Counsel issued a legal opinion that clarifies its position on several important hemp-related provisions of the 2018 Farm Bill, including the legality of hemp in interstate commerce and…

It’s Time to Set the Record Straight – CBD Is “Psychoactive”

By Ian A. Stewart The media loves to say that CBD (cannabidiol) is “non-psychoactive.” The frequency with which this statement is repeated rises with the popularity of CBD. Most commentators who use the term “non-psychoactive” likely mean to say that…

FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing

By Ian Stewart & Neil Willner Attorneys at Wilson Elser On April 2, 2019, the U.S. Food and Drug Administration (FDA) issued a sweeping press release from outgoing Commissioner Scott Gottlieb covering new steps to advance the agency’s continued evaluation…

Market Confusion on CBD and Hemp; FDA Commissioner Resigns amid Congressional Pressure for Federal Guidance

By Ian Stewart & Neil Willner The Commissioner of the Food and Drug Administration (FDA), Scott Gottlieb MD, who has received high marks for his leadership of the agency since May 2017, announced his resignation on March 5, 2019, stating that…

Federal Courts Are Split on the Legality of Transporting Hemp and CBD in Interstate Commerce

February 19, 2019
Ian Stewart
News & Insights, Policy & Legal, Press Releases, Science and Technology
0 Comments

By Ian Stewart When the 2018 Farm Bill was signed by President Trump on December 20, 2018, there was widespread optimism that hemp and hemp-derived products, including cannabidiol (CBD), soon would be freely moving in interstate commerce without interference by…

FDA Updates its Position on CBD upon Signing of Farm Bill

January 2, 2019
Ian Stewart
Cultivation, Hemp Policy & Legal, News & Insights, Policy & Legal, Retail
0 Comments

Hours after President Trump signed the 2018 Farm Bill into law, the FDA released a lengthy statement from its commissioner, Scott Gottlieb, M.D., updating its position on CBD products intended for human consumption. Flexing its muscle, the FDA points out…

Will California’s Section 5032 Disrupt the Cannabis Market?

By Ian Stewart On December 7, 2018, California’s three cannabis licensing authorities submitted final versions of the state cannabis regulations scheduled to be approved by January 16, 2019. California’s Bureau of Cannabis Control (Bureau) submitted a final version of Section…

Will Hemp-Derived CBD Be Fully Legal with Passage of the 2018 Farm Bill? Not Quite…

December 5, 2018
Ian Stewart
California, Cannabis Investments, Compliance and Regulations, Hemp Business Executive, Hemp Industry News, Hemp Policy & Legal, News & Insights, Policy & Legal
0 Comments

By Ian Stewart, Wilson Elser Public interest in the potential health benefits of CBD (cannabidiol) is responsible for a whole new market segment of health and wellness foods and supplements that features CBD as an ingredient. CBD is one of…